首页> 美国卫生研究院文献>other >Microribbon-based hydrogels accelerate stem cell-based bone regeneration in a mouse critical-size cranial defect model
【2h】

Microribbon-based hydrogels accelerate stem cell-based bone regeneration in a mouse critical-size cranial defect model

机译:基于微带的水凝胶可在小鼠关键尺寸颅骨缺损模型中加速基于干细胞的骨再生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stem cell-based therapies hold great promise for enhancing tissue regeneration. However, the majority of cells die shortly after transplantation, which greatly diminishes the efficacy of stem cell-based therapies. Poor cell engraftment and survival remain a major bottleneck to fully exploiting the power of stem cells for regenerative medicine. Biomaterials such as hydrogels can serve as artificial matrices to protect cells during delivery and guide desirable cell fates. However, conventional hydrogels often lack macroporosity, which restricts cell proliferation and delays matrix deposition. Here we report the use of injectable, macroporous microribbon (µRB) hydrogels as stem cell carriers for bone repair, which supports direct cell encapsulation into a macroporous scaffold with rapid spreading. When transplanted in a criticalsized, mouse cranial defect model, µRB-based hydrogels significantly enhanced the survival of transplanted adipose-derived stromal cells (ADSCs) (81%) and enabled up to three-fold cell proliferation after 7 days. In contrast, conventional hydrogels only led to 27% cell survival, which continued to decrease over time. MicroCT imaging showed µRBs enhanced and accelerated mineralized bone repair compared to hydrogels (61% vs. 34% by week 6), and stem cells were required for bone repair to occur. These results suggest that paracrine signaling of transplanted stem cells are responsible for the observed bone repair, and enhancing cell survival and proliferation using µRBs further promoted the paracrine-signaling effects of ADSCs for stimulating endogenous bone repair. We envision µRB-based scaffolds can be broadly useful as a novel scaffold for enhancing stem cell survival and regeneration of other tissue types.
机译:基于干细胞的疗法有望增强组织再生。但是,大多数细胞在移植后不久就会死亡,这大大降低了基于干细胞疗法的疗效。细胞植入率低和存活率仍然是充分利用干细胞再生医学功能的主要瓶颈。生物材料(例如水凝胶)可以用作人造基质,以在分娩过程中保护细胞并指导所需的细胞命运。然而,常规的水凝胶通常缺乏大孔性,这限制了细胞增殖并延迟了基质沉积。在这里,我们报道了可注射的大孔微带(µRB)水凝胶作为骨修复的干细胞载体的用途,它支持将细胞直接包封到具有快速扩散作用的大孔支架中。当以临界大小的小鼠颅骨缺损模型移植时,基于µRB的水凝胶可显着提高移植的脂肪基质细胞(ADSC)的存活率(81%),并在7天后达到三倍的细胞增殖能力。相反,常规水凝胶仅导致27%的细胞存活率,并随着时间的推移持续下降。 MicroCT成像显示,与水凝胶相比,µRBs增强和加速了矿化的骨修复(到第6周时分别为61%和34%),并且需要干细胞来进行骨修复。这些结果表明,移植干细胞的旁分泌信号负责观察到的骨修复,并且使用µRBs增强细胞存活和增殖进一步促进了ADSC刺激内源性骨修复的旁分泌信号作用。我们设想基于µRB的支架可以广泛用作增强干细胞存活和其他组织类型再生的新型支架。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号